Looks good, Jeff Hughes also presenting after Mustafa Atee that day. Jeff Hughes was interim CEO before Daffas came on board and he is now the Scientific Officer for PainChek.
Low volume retrace so far today which looks promising from a technical perspective. Fair value for PCK is well above these levels and the deals which they seem to be working on integrating will justify this.
PainChek General Discussion, page-265
Add PCK (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.1¢ |
Change
0.001(3.33%) |
Mkt cap ! $50.71M | |||
| Open | High | Low | Value | Volume |
| 3.0¢ | 3.1¢ | 2.9¢ | $39.10K | 1.271M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 957373 | 2.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.1¢ | 175237 | 1 |
View Market Depth
| Last trade - 16.10pm 26/04/2024 (20 minute delay) ? |
|
|||||
|
Last
3.1¢ |
Change
0.001 ( 3.33 %) |
||||
| Open | High | Low | Volume | ||
| 3.1¢ | 3.1¢ | 2.9¢ | 76478 | ||
| Last updated 11.56am 26/04/2024 ? | |||||
| PCK (ASX) Chart |